Zota Health Care Limited (ZOTA.NS)
INR 883.3
(2.2%)
INR 883.3
(2.2%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 631.64 Million INR | 74.18% |
| 2022 | 362.63 Million INR | 190.96% |
| 2021 | 124.63 Million INR | 0.0% |
| 2020 | - INR | 0.0% |
| 2019 | - INR | 0.0% |
| 2018 | - INR | 0.0% |
| 2017 | - INR | -100.0% |
| 2016 | 24.57 Million INR | 10.36% |
| 2015 | 22.26 Million INR | 11.33% |
| 2014 | 19.99 Million INR | -37.43% |
| 2013 | 31.96 Million INR | 5.58% |
| 2012 | 30.27 Million INR | 2.19% |
| 2011 | 29.62 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | 0.0% |
| 2023 Q2 | 504.44 Million INR | 0.0% |
| 2023 FY | 631.64 Million INR | 74.18% |
| 2023 Q4 | 631.64 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q4 | 362.63 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 362.63 Million INR | 190.96% |
| 2022 Q2 | 314.46 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 FY | 124.63 Million INR | 0.0% |
| 2021 Q3 | - INR | 0.0% |
| 2021 Q2 | - INR | 0.0% |
| 2021 Q4 | 124.63 Million INR | 0.0% |
| 2020 Q1 | - INR | 0.0% |
| 2020 FY | - INR | 0.0% |
| 2020 Q4 | - INR | 0.0% |
| 2020 Q3 | - INR | 0.0% |
| 2020 Q2 | - INR | 0.0% |
| 2019 Q4 | - INR | 0.0% |
| 2019 FY | - INR | 0.0% |
| 2019 Q3 | - INR | 0.0% |
| 2019 Q2 | - INR | 0.0% |
| 2018 FY | - INR | 0.0% |
| 2018 Q4 | - INR | 0.0% |
| 2018 Q2 | - INR | 0.0% |
| 2017 Q2 | - INR | 0.0% |
| 2017 Q4 | - INR | 0.0% |
| 2017 FY | - INR | -100.0% |
| 2016 Q1 | 22.26 Million INR | 0.0% |
| 2016 FY | 24.57 Million INR | 10.36% |
| 2016 Q4 | 24.57 Million INR | 7.73% |
| 2016 Q3 | 22.8 Million INR | 0.0% |
| 2015 FY | 22.26 Million INR | 11.33% |
| 2014 FY | 19.99 Million INR | -37.43% |
| 2013 FY | 31.96 Million INR | 5.58% |
| 2012 FY | 30.27 Million INR | 2.19% |
| 2011 FY | 29.62 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Biocon Limited | 129.32 Billion INR | 99.512% |
| Blue Jet Healthcare Limited | 3.79 Million INR | -16566.016% |
| Concord Biotech Limited | 18.87 Million INR | -3247.334% |
| Dishman Carbogen Amcis Limited | 2.45 Billion INR | 74.283% |
| Jubilant Ingrevia Limited | 4.25 Billion INR | 85.158% |
| Lyka Labs Limited | 429.06 Million INR | -47.213% |
| Panacea Biotec Limited | 209.9 Million INR | -200.925% |
| Piramal Pharma Limited | 24.83 Billion INR | 97.457% |
| SMS Lifesciences India Limited | 331.45 Million INR | -90.569% |
| Supriya Lifescience Limited | 50.2 Million INR | -1158.251% |
| Syngene International Limited | 1 Billion INR | 36.836% |
| TAKE Solutions Limited | 7.5 Million INR | -8321.893% |